Plasma anthocyanins and their metabolites reduce in vitro migration of pancreatic cancer cells, PANC-1, in a FAK- and NF-kB dependent manner: Results from the ATTACH-study a randomized, controlled, crossover trial in healthy subjects

Pancreatic cancer is primarily considered to be a metastatic disease with a low 5-year survival rate. We aimed to detect if plasma-isolated anthocyanins and their metabolites (PAMs) modulate pancreatic cancer cells migration and to describe molecular targets of PAMs in this process. Plasma metabolit...

Full description

Saved in:
Bibliographic Details
Published inBiomedicine & pharmacotherapy Vol. 158; p. 114076
Main Authors Mostafa, Hamza, Behrendt, Inken, Meroño, Tomás, González-Domínguez, Raúl, Fasshauer, Mathias, Rudloff, Silvia, Andres-Lacueva, Cristina, Kuntz, Sabine
Format Journal Article
LanguageEnglish
Published France Elsevier Masson SAS 01.02.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Pancreatic cancer is primarily considered to be a metastatic disease with a low 5-year survival rate. We aimed to detect if plasma-isolated anthocyanins and their metabolites (PAMs) modulate pancreatic cancer cells migration and to describe molecular targets of PAMs in this process. Plasma metabolites were isolated by solid-phase extraction before and after a 28-days intervention trial involving 35 healthy subjects comparing effects of a daily anthocyanin-rich juice intake vs. placebo. Plasma extracts were used for migration and mechanistic in vitro studies as well as for metabolomic analysis. Pancreatic PANC-1 and AsPC-1 were used for migration studies in a Boyden chamber co-cultured with endothelial cells. Expression of adhesion molecules on cancer and endothelial cells were determined by flow cytometry and NF-kB (nuclear factor-kappa B) p65 and focal adhesion kinase activation were measured by immunoassays. UHPLC-MS/MS metabolomics was done in plasma and urine samples. Plasma extracts isolated after the intake of the anthocyanin-rich juice significantly reduced PANC-1 migration, but not AsPC-1 migration. In PANC-1, and to a lower extent in endothelial cells, plasma extracts after juice intake decreased the expression of ß1- and ß4-integrins and intercellular adhesion molecule-1. Pooled plasma from volunteers with the highest inhibition of PANC-1 migration (n = 10) induced a reduction of NF-kB-p65 and FAK-phosphorylation in cancer and in endothelial cells. Concerning metabolites, 14 were significantly altered by juice intervention and PANC-1 migration was inversely associated with the increase of o-coumaric acid and peonidin-3-galactoside. PAMs were associated with lower PANC-1 cell migration opening new strategies for metastatic pancreatic cancer treatment. [Display omitted] •Pancreatic cancer cells are characterized by early and invasive metastatic potential.•Plasma extracts after ACN intake reduced PANC-1 migration.•Plasma extracts inhibited the expression of CAMs via FAK and NF-KB pathways.•Microbial phenolic metabolites of ACNs were associated with PANC-1 migration.•ACNs-based strategies may help in metastatic pancreatic cancer treatment.
AbstractList Pancreatic cancer is primarily considered to be a metastatic disease with a low 5-year survival rate. We aimed to detect if plasma-isolated anthocyanins and their metabolites (PAMs) modulate pancreatic cancer cells migration and to describe molecular targets of PAMs in this process. Plasma metabolites were isolated by solid-phase extraction before and after a 28-days intervention trial involving 35 healthy subjects comparing effects of a daily anthocyanin-rich juice intake vs. placebo. Plasma extracts were used for migration and mechanistic in vitro studies as well as for metabolomic analysis. Pancreatic PANC-1 and AsPC-1 were used for migration studies in a Boyden chamber co-cultured with endothelial cells. Expression of adhesion molecules on cancer and endothelial cells were determined by flow cytometry and NF-kB (nuclear factor-kappa B) p65 and focal adhesion kinase activation were measured by immunoassays. UHPLC-MS/MS metabolomics was done in plasma and urine samples. Plasma extracts isolated after the intake of the anthocyanin-rich juice significantly reduced PANC-1 migration, but not AsPC-1 migration. In PANC-1, and to a lower extent in endothelial cells, plasma extracts after juice intake decreased the expression of ß1- and ß4-integrins and intercellular adhesion molecule-1. Pooled plasma from volunteers with the highest inhibition of PANC-1 migration (n = 10) induced a reduction of NF-kB-p65 and FAK-phosphorylation in cancer and in endothelial cells. Concerning metabolites, 14 were significantly altered by juice intervention and PANC-1 migration was inversely associated with the increase of o-coumaric acid and peonidin-3-galactoside. PAMs were associated with lower PANC-1 cell migration opening new strategies for metastatic pancreatic cancer treatment.Pancreatic cancer is primarily considered to be a metastatic disease with a low 5-year survival rate. We aimed to detect if plasma-isolated anthocyanins and their metabolites (PAMs) modulate pancreatic cancer cells migration and to describe molecular targets of PAMs in this process. Plasma metabolites were isolated by solid-phase extraction before and after a 28-days intervention trial involving 35 healthy subjects comparing effects of a daily anthocyanin-rich juice intake vs. placebo. Plasma extracts were used for migration and mechanistic in vitro studies as well as for metabolomic analysis. Pancreatic PANC-1 and AsPC-1 were used for migration studies in a Boyden chamber co-cultured with endothelial cells. Expression of adhesion molecules on cancer and endothelial cells were determined by flow cytometry and NF-kB (nuclear factor-kappa B) p65 and focal adhesion kinase activation were measured by immunoassays. UHPLC-MS/MS metabolomics was done in plasma and urine samples. Plasma extracts isolated after the intake of the anthocyanin-rich juice significantly reduced PANC-1 migration, but not AsPC-1 migration. In PANC-1, and to a lower extent in endothelial cells, plasma extracts after juice intake decreased the expression of ß1- and ß4-integrins and intercellular adhesion molecule-1. Pooled plasma from volunteers with the highest inhibition of PANC-1 migration (n = 10) induced a reduction of NF-kB-p65 and FAK-phosphorylation in cancer and in endothelial cells. Concerning metabolites, 14 were significantly altered by juice intervention and PANC-1 migration was inversely associated with the increase of o-coumaric acid and peonidin-3-galactoside. PAMs were associated with lower PANC-1 cell migration opening new strategies for metastatic pancreatic cancer treatment.
Pancreatic cancer is primarily considered to be a metastatic disease with a low 5-year survival rate. We aimed to detect if plasma-isolated anthocyanins and their metabolites (PAMs) modulate pancreatic cancer cells migration and to describe molecular targets of PAMs in this process. Plasma metabolites were isolated by solid-phase extraction before and after a 28-days intervention trial involving 35 healthy subjects comparing effects of a daily anthocyanin-rich juice intake vs. placebo. Plasma extracts were used for migration and mechanistic in vitro studies as well as for metabolomic analysis. Pancreatic PANC-1 and AsPC-1 were used for migration studies in a Boyden chamber co-cultured with endothelial cells. Expression of adhesion molecules on cancer and endothelial cells were determined by flow cytometry and NF-kB (nuclear factor-kappa B) p65 and focal adhesion kinase activation were measured by immunoassays. UHPLC-MS/MS metabolomics was done in plasma and urine samples. Plasma extracts isolated after the intake of the anthocyanin-rich juice significantly reduced PANC-1 migration, but not AsPC-1 migration. In PANC-1, and to a lower extent in endothelial cells, plasma extracts after juice intake decreased the expression of ß1- and ß4-integrins and intercellular adhesion molecule-1. Pooled plasma from volunteers with the highest inhibition of PANC-1 migration (n = 10) induced a reduction of NF-kB-p65 and FAK-phosphorylation in cancer and in endothelial cells. Concerning metabolites, 14 were significantly altered by juice intervention and PANC-1 migration was inversely associated with the increase of o-coumaric acid and peonidin-3-galactoside. PAMs were associated with lower PANC-1 cell migration opening new strategies for metastatic pancreatic cancer treatment.
Pancreatic cancer is primarily considered to be a metastatic disease with a low 5-year survival rate. We aimed to detect if plasma-isolated anthocyanins and their metabolites (PAMs) modulate pancreatic cancer cells migration and to describe molecular targets of PAMs in this process. Plasma metabolites were isolated by solid-phase extraction before and after a 28-days intervention trial involving 35 healthy subjects comparing effects of a daily anthocyanin-rich juice intake vs. placebo. Plasma extracts were used for migration and mechanistic in vitro studies as well as for metabolomic analysis. Pancreatic PANC-1 and AsPC-1 were used for migration studies in a Boyden chamber co-cultured with endothelial cells. Expression of adhesion molecules on cancer and endothelial cells were determined by flow cytometry and NF-kB (nuclear factor-kappa B) p65 and focal adhesion kinase activation were measured by immunoassays. UHPLC-MS/MS metabolomics was done in plasma and urine samples. Plasma extracts isolated after the intake of the anthocyanin-rich juice significantly reduced PANC-1 migration, but not AsPC-1 migration. In PANC-1, and to a lower extent in endothelial cells, plasma extracts after juice intake decreased the expression of ß1- and ß4-integrins and intercellular adhesion molecule-1. Pooled plasma from volunteers with the highest inhibition of PANC-1 migration (n = 10) induced a reduction of NF-kB-p65 and FAK-phosphorylation in cancer and in endothelial cells. Concerning metabolites, 14 were significantly altered by juice intervention and PANC-1 migration was inversely associated with the increase of o-coumaric acid and peonidin-3-galactoside. PAMs were associated with lower PANC-1 cell migration opening new strategies for metastatic pancreatic cancer treatment. [Display omitted] •Pancreatic cancer cells are characterized by early and invasive metastatic potential.•Plasma extracts after ACN intake reduced PANC-1 migration.•Plasma extracts inhibited the expression of CAMs via FAK and NF-KB pathways.•Microbial phenolic metabolites of ACNs were associated with PANC-1 migration.•ACNs-based strategies may help in metastatic pancreatic cancer treatment.
ArticleNumber 114076
Author Mostafa, Hamza
Meroño, Tomás
Kuntz, Sabine
Fasshauer, Mathias
González-Domínguez, Raúl
Andres-Lacueva, Cristina
Rudloff, Silvia
Behrendt, Inken
Author_xml – sequence: 1
  givenname: Hamza
  orcidid: 0000-0003-4319-9542
  surname: Mostafa
  fullname: Mostafa, Hamza
  organization: Biomarkers and Nutrimetabolomics Laboratory, Department of Nutrition, Food Sciences and Gastronomy, Food Innovation Network (XIA), Nutrition and Food Safety Research Institute (INSA), Facultat de Farmàcia i Ciències de l′Alimentació, Universitat de Barcelona (UB), 08028 Barcelona, Spain
– sequence: 2
  givenname: Inken
  surname: Behrendt
  fullname: Behrendt, Inken
  email: inken.behrendt@ernaehrung.uni-giessen.de
  organization: Department of Nutritional Science, Human Nutrition, Justus-Liebig-University, 35390 Giessen, Germany
– sequence: 3
  givenname: Tomás
  orcidid: 0000-0002-2673-3494
  surname: Meroño
  fullname: Meroño, Tomás
  email: tomasmerono@ub.edu
  organization: Biomarkers and Nutrimetabolomics Laboratory, Department of Nutrition, Food Sciences and Gastronomy, Food Innovation Network (XIA), Nutrition and Food Safety Research Institute (INSA), Facultat de Farmàcia i Ciències de l′Alimentació, Universitat de Barcelona (UB), 08028 Barcelona, Spain
– sequence: 4
  givenname: Raúl
  surname: González-Domínguez
  fullname: González-Domínguez, Raúl
  organization: Biomarkers and Nutrimetabolomics Laboratory, Department of Nutrition, Food Sciences and Gastronomy, Food Innovation Network (XIA), Nutrition and Food Safety Research Institute (INSA), Facultat de Farmàcia i Ciències de l′Alimentació, Universitat de Barcelona (UB), 08028 Barcelona, Spain
– sequence: 5
  givenname: Mathias
  surname: Fasshauer
  fullname: Fasshauer, Mathias
  organization: Department of Nutritional Science, Human Nutrition, Justus-Liebig-University, 35390 Giessen, Germany
– sequence: 6
  givenname: Silvia
  surname: Rudloff
  fullname: Rudloff, Silvia
  organization: Department of Nutritional Science, Human Nutrition, Justus-Liebig-University, 35390 Giessen, Germany
– sequence: 7
  givenname: Cristina
  surname: Andres-Lacueva
  fullname: Andres-Lacueva, Cristina
  organization: Biomarkers and Nutrimetabolomics Laboratory, Department of Nutrition, Food Sciences and Gastronomy, Food Innovation Network (XIA), Nutrition and Food Safety Research Institute (INSA), Facultat de Farmàcia i Ciències de l′Alimentació, Universitat de Barcelona (UB), 08028 Barcelona, Spain
– sequence: 8
  givenname: Sabine
  surname: Kuntz
  fullname: Kuntz, Sabine
  organization: Department of Nutritional Science, Human Nutrition, Justus-Liebig-University, 35390 Giessen, Germany
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36516693$$D View this record in MEDLINE/PubMed
BookMark eNqFUk2P0zAQjdAi9gP-AUI-cmiK7SROskIrlYoCYrWsUDlbjj2l7jp2sZ1K5R_zL3Da3cteevKM9N6b8Zt3mZ1ZZyHL3hI8JZiwD5tpp912LaYUUzolpMQ1e5FdkLbCOcO4PssucF0VeVFQep5dhrDBGFesaF5l5wWrCGNtcZH9uzci9AIJG9dO7oXVNqRGobgG7VEPUXTO6AgBeVCDBKQt2unoHer1by-idha5FdoKKz2kViKZSvBIgjFhgu5nd_OcTEaaQIvZ9_ygfrfIHz4hBVuwCmxEvbAW_DX6CWEwMaCVd_24Apotl7P51zzEQe2TgE9k1-u_oCZIOpvWMOZQexeC26Wx0WthxmlrECau9ygM3QZkDK-zlythArx5fK-yX4vPy6R9--PLt_nsNpclIzFXtKzruu2wpCC7RgKm0LVdW3RQSmiEwAR3K5CVKLEsS4WpYKzGDcXAaFtDcZW9P-puvfszQIi812E0Q1hwQ-C0rsqG4aYqEvTdI3ToelB863Uv_J4_nScBro-Aw_88rLjU8eB59EIbTjAfs8A3_JgFPmaBH7OQyOUz8pP-CdrNkQbJpJ0Gz4PUkE6qtE8-cuX0KYGPzwSk0VZLYR5gf5r-H-2x5tA
CitedBy_id crossref_primary_10_1002_ptr_8124
crossref_primary_10_3390_pharmaceutics16020157
crossref_primary_10_3389_fnut_2024_1477140
crossref_primary_10_3390_metabo14040203
crossref_primary_10_1007_s00210_024_03396_x
crossref_primary_10_1186_s12935_025_03673_6
crossref_primary_10_3390_biomedicines12030482
crossref_primary_10_25259_Cytojournal_105_2024
crossref_primary_10_3390_pharmaceutics16010152
crossref_primary_10_1016_j_foodres_2023_113252
crossref_primary_10_3390_foods12091796
crossref_primary_10_3390_foods13244066
Cites_doi 10.1021/acs.jafc.6b05455
10.1016/j.ccell.2018.11.016
10.1158/1055-9965.EPI-05-0226
10.32471/exp-oncology.2312-8852.vol-42-no-2.14766
10.1210/clinem/dgz224
10.1016/j.ceb.2006.08.011
10.1016/j.freeradbiomed.2003.12.017
10.1111/1541-4337.12836
10.1007/s12029-012-9441-y
10.1038/s41598-019-55505-z
10.3390/cancers11030427
10.3390/ijms21176239
10.1016/j.foodchem.2021.129831
10.1007/s12010-012-9752-2
10.1016/j.bmcl.2017.09.024
10.3109/07357900902769749
10.1093/mutage/geu009
10.1021/acs.analchem.0c02008
10.3892/mmr.2016.4990
10.1207/s15327914nc5301_1
10.1016/j.mrgentox.2012.01.011
10.1002/mc.21974
10.1007/s00394-015-1070-3
10.1016/j.ccell.2019.01.007
10.1007/s10552-012-9992-z
10.1021/acs.jafc.8b06737
ContentType Journal Article
Copyright 2022
Copyright © 2022. Published by Elsevier Masson SAS.
Copyright_xml – notice: 2022
– notice: Copyright © 2022. Published by Elsevier Masson SAS.
DBID 6I.
AAFTH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.biopha.2022.114076
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
EISSN 1950-6007
ExternalDocumentID 36516693
10_1016_j_biopha_2022_114076
S0753332222014652
Genre Randomized Controlled Trial
Journal Article
GroupedDBID ---
--K
--M
.1-
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
23N
4.4
457
4CK
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
AABNK
AAEDT
AAEDW
AAFWJ
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABMAC
ABMZM
ABWVN
ABXDB
ABZDS
ACDAQ
ACIEU
ACIUM
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
ADVLN
AEBSH
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGUBO
AGYEJ
AHHHB
AI.
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
DU5
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HMT
HVGLF
HZ~
IHE
J1W
KOM
M34
M41
MO0
N9A
O-L
O9-
OAUVE
OD~
OGGZJ
OK1
OO0
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SDF
SDG
SDP
SEM
SES
SEW
SPT
SSH
SSP
SSZ
T5K
VH1
WUQ
Z5R
~02
~G-
0SF
6I.
AACTN
AAFTH
AAIAV
AATCM
ABLVK
ABYKQ
AFCTW
AFKWA
AFPKN
AJBFU
AJOXV
AMFUW
EFLBG
GROUPED_DOAJ
LCYCR
NCXOZ
RIG
AAYXX
AGRNS
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c461t-d247779b0c2ecb8ce02eb9b93be4ce8aa010bfec5a40c44d02a6670820e6297e3
IEDL.DBID .~1
ISSN 0753-3322
1950-6007
IngestDate Fri Jul 11 10:50:14 EDT 2025
Mon Jul 21 05:37:47 EDT 2025
Tue Jul 01 04:13:10 EDT 2025
Thu Apr 24 23:12:47 EDT 2025
Fri Feb 23 02:39:00 EST 2024
Tue Aug 26 16:32:11 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords Metabolomics
FAK
Pancreatic cancer cells
Migration
ROS
Anthocyanins
Adhesion molecules
HUVEC
TEER
ACN
CAM
Language English
License This is an open access article under the CC BY-NC-ND license.
Copyright © 2022. Published by Elsevier Masson SAS.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c461t-d247779b0c2ecb8ce02eb9b93be4ce8aa010bfec5a40c44d02a6670820e6297e3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
ORCID 0000-0002-2673-3494
0000-0003-4319-9542
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S0753332222014652
PMID 36516693
PQID 2754860853
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2754860853
pubmed_primary_36516693
crossref_citationtrail_10_1016_j_biopha_2022_114076
crossref_primary_10_1016_j_biopha_2022_114076
elsevier_sciencedirect_doi_10_1016_j_biopha_2022_114076
elsevier_clinicalkey_doi_10_1016_j_biopha_2022_114076
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate February 2023
2023-02-00
2023-Feb
20230201
PublicationDateYYYYMMDD 2023-02-01
PublicationDate_xml – month: 02
  year: 2023
  text: February 2023
PublicationDecade 2020
PublicationPlace France
PublicationPlace_xml – name: France
PublicationTitle Biomedicine & pharmacotherapy
PublicationTitleAlternate Biomed Pharmacother
PublicationYear 2023
Publisher Elsevier Masson SAS
Publisher_xml – name: Elsevier Masson SAS
References Mitra, Schlaepfer (bib28) 2006; 18
Sankaranarayanan, Valiveti, Kumar, Van Slambrouck, Kesharwani, Seefeldt, Scaria, Tummala, Bhat (bib23) 2019; 11
Li, Xu, Tang, Liu, Yu, Wang, Liu (bib27) 2016; 13
Liu, Martin, Valdez, Sudakaran, Rey, Bolling (bib9) 2021; 359
Forester, Choy, Waterhouse, Oteiza (bib22) 2014; 53
Augusti, Quatrin, Mello, Bochi, Rodrigues, Prazeres, Macedo, Oliveira-Alves, Emanuelli, Bronze (bib24) 2021
Shen, Jiang, Wei, Ell, Sheng, Esposito, Kang, Hang, Zheng, Rowicki (bib29) 2019; 35
Behrendt, Röder, Will, Mostafa, Gonzalez-Dominguez, Meroño, Andres-Lacueva, Fasshauer, Rudloff, Kuntz (bib15) 2022; Vol. 11
Huang, Hung, Hung, Lin, Wang, Kao (bib19) 2019; 9
Kuntz, Kunz, Rudloff (bib14) 2017; 56
Higgins, Zainol, Brown, Jones (bib26) 2014; 29
Maatta, K.-E.A, T.R (bib8) 2001
Rubert, Gatto, Pancher, Sidarovich, Curti, Mena, Del Rio, Quattrone, Mattivi (bib12) 2022; 2101043
Abraham, Eckhardt, Oli, Stopper (bib25) 2012; 744
Lamdan, Garcia-Lazaro, Lorenzo, Caligiuri, Alonso, Farina (bib13) 2020; 42
Grimm, Schäfer, Högger (bib30) 2004; 36
Jansen, Robinson, Stolzenberg-Solomon, Bamlet, De Andrade, Oberg, Rabe, Anderson, Olson, Sinha (bib7) 2013; 44
Lim, Kim, Kim, Park, Song, Lee, Lee, Lee, So, Choi (bib18) 2017; 27
Chan, Wang, Holly (bib5) 2005; 14
Jokioja, Yang, Linderborg (bib11) 2021; 20
Zamora-Ros, Not, Guinó, Luján-Barroso, García, Biondo, Salazar, Moreno (bib20) 2013; 24
Makrilia, Kollias, Manolopoulos, Syrigos (bib2) 2009; 27
López De Las Hazas, Mosele, Macià, Ludwig, Motilva (bib10) 2017; 65
Kalt, McDonald, Liu, Fillmore (bib21) 2017; 65
González-Domínguez, Jáuregui, Queipo-Ortuño, Andrés-Lacueva (bib16) 2020; 92
Zeeshan, Mutahir (bib3) 2017; 17
Wang, Ni, Sun, Xu, Xie, Zhang, Fang, Ning, Wang (bib32) 2020; 105
Guerrero, Miró, Wong, Massaguer, Martínez-Bosch, de Llorens, Navarro, Konstantopoulos, Llop, Peracaula (bib1) 2020; 21
Krga, Milenkovic (bib31) 2019; 67
Lunet, Lacerda-Vieira, Barros (bib6) 2005; 53
Zhou, Chiu, Qin, Niu, Cai, He, Huang, Xu (bib17) 2012; 167
Cooper, Giancotti (bib4) 2019; 35
Kuntz (10.1016/j.biopha.2022.114076_bib14) 2017; 56
Sankaranarayanan (10.1016/j.biopha.2022.114076_bib23) 2019; 11
Zhou (10.1016/j.biopha.2022.114076_bib17) 2012; 167
Liu (10.1016/j.biopha.2022.114076_bib9) 2021; 359
Wang (10.1016/j.biopha.2022.114076_bib32) 2020; 105
Kalt (10.1016/j.biopha.2022.114076_bib21) 2017; 65
Rubert (10.1016/j.biopha.2022.114076_bib12) 2022; 2101043
González-Domínguez (10.1016/j.biopha.2022.114076_bib16) 2020; 92
Maatta (10.1016/j.biopha.2022.114076_bib8) 2001
Shen (10.1016/j.biopha.2022.114076_bib29) 2019; 35
Higgins (10.1016/j.biopha.2022.114076_bib26) 2014; 29
Li (10.1016/j.biopha.2022.114076_bib27) 2016; 13
Lim (10.1016/j.biopha.2022.114076_bib18) 2017; 27
Cooper (10.1016/j.biopha.2022.114076_bib4) 2019; 35
Jokioja (10.1016/j.biopha.2022.114076_bib11) 2021; 20
Zamora-Ros (10.1016/j.biopha.2022.114076_bib20) 2013; 24
López De Las Hazas (10.1016/j.biopha.2022.114076_bib10) 2017; 65
Krga (10.1016/j.biopha.2022.114076_bib31) 2019; 67
Chan (10.1016/j.biopha.2022.114076_bib5) 2005; 14
Guerrero (10.1016/j.biopha.2022.114076_bib1) 2020; 21
Lunet (10.1016/j.biopha.2022.114076_bib6) 2005; 53
Huang (10.1016/j.biopha.2022.114076_bib19) 2019; 9
Makrilia (10.1016/j.biopha.2022.114076_bib2) 2009; 27
Augusti (10.1016/j.biopha.2022.114076_bib24) 2021
Jansen (10.1016/j.biopha.2022.114076_bib7) 2013; 44
Grimm (10.1016/j.biopha.2022.114076_bib30) 2004; 36
Zeeshan (10.1016/j.biopha.2022.114076_bib3) 2017; 17
Forester (10.1016/j.biopha.2022.114076_bib22) 2014; 53
Behrendt (10.1016/j.biopha.2022.114076_bib15) 2022; Vol. 11
Abraham (10.1016/j.biopha.2022.114076_bib25) 2012; 744
Lamdan (10.1016/j.biopha.2022.114076_bib13) 2020; 42
Mitra (10.1016/j.biopha.2022.114076_bib28) 2006; 18
References_xml – volume: 167
  start-page: 2257
  year: 2012
  end-page: 2268
  ident: bib17
  article-title: Detection and clinical significance of cd44v6 and integrin-β1 in pancreatic cancer patients using a triplex real-time RT-PCR assay
  publication-title: Appl. Biochem. Biotechnol.
– volume: 2101043
  start-page: 1
  year: 2022
  end-page: 10
  ident: bib12
  article-title: A Screening of Native (Poly)phenols and Gut-Related Metabolites on 3D HCT116 Spheroids Reveals Gut Health Benefits of a Flavan-3-ol Metabolite
  publication-title: Mol. Nutr. Food Res.
– volume: 35
  start-page: 64
  year: 2019
  end-page: 80
  ident: bib29
  article-title: Tinagl1 Suppresses Triple-Negative Breast Cancer Progression and Metastasis by Simultaneously Inhibiting Integrin/FAK and EGFR Signaling
  publication-title: Cancer Cell
– volume: 44
  start-page: 152
  year: 2013
  end-page: 161
  ident: bib7
  article-title: Nutrients from fruit and vegetable consumption reduce the risk of pancreatic cancer
  publication-title: J. Gastrointest. Cancer
– volume: 14
  start-page: 2093
  year: 2005
  end-page: 2097
  ident: bib5
  article-title: Vegetable and fruit intake and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area
  publication-title: Cancer Epidemiol. Biomark. Prev.
– volume: 17
  start-page: 172
  year: 2017
  end-page: 182
  ident: bib3
  article-title: Cancer metastasis - Tricks of the trade
  publication-title: Bosn. J. Basic Med. Sci.
– volume: 20
  start-page: 5570
  year: 2021
  end-page: 5615
  ident: bib11
  article-title: Acylated anthocyanins: a review on their bioavailability and effects on postprandial carbohydrate metabolism and inflammation
  publication-title: Compr. Rev. Food Sci. Food Saf.
– volume: 92
  start-page: 13767
  year: 2020
  end-page: 13775
  ident: bib16
  article-title: Characterization of the Human Exposome by a Comprehensive and Quantitative Large-Scale Multianalyte Metabolomics Platform
  publication-title: Anal. Chem.
– volume: 65
  start-page: 1582
  year: 2017
  end-page: 1591
  ident: bib21
  article-title: Flavonoid metabolites in human urine during blueberry anthocyanin intake
  publication-title: J. Agric. Food Chem.
– volume: Vol. 11
  year: 2022
  ident: bib15
  article-title: Influence of Plasma-Isolated Anthocyanins and Their Metabolites on Cancer Cell Migration (HT-29 and Caco-2) In Vitro: Results of the ATTACH Study
  publication-title: Antioxidants 2022
– volume: 29
  start-page: 227
  year: 2014
  end-page: 235
  ident: bib26
  article-title: Anthocyans as tertiary chemopreventive agents in bladder cancer: anti-oxidant mechanisms and interaction with mitomycin C
  publication-title: Mutagenesis
– volume: 67
  start-page: 1771
  year: 2019
  end-page: 1783
  ident: bib31
  article-title: Anthocyanins: from sources and bioavailability to cardiovascular- health benefits and molecular mechanisms of action
  publication-title: J. Agric. Food Chem.
– volume: 35
  start-page: 347
  year: 2019
  end-page: 367
  ident: bib4
  article-title: Integrin signaling in cancer: mechanotransduction, stemness, epithelial plasticity, and therapeutic resistance
  publication-title: Cancer Cell
– volume: 359
  year: 2021
  ident: bib9
  article-title: Aronia berry polyphenols have matrix-dependent effects on the gut microbiota
  publication-title: Food Chem.
– volume: 65
  start-page: 6477
  year: 2017
  end-page: 6487
  ident: bib10
  article-title: Exploring the colonic metabolism of grape and strawberry anthocyanins and their in vitro apoptotic effects in HT-29 colon cancer cells
  publication-title: Antioxid. Redox Signal.
– volume: 24
  start-page: 549
  year: 2013
  end-page: 557
  ident: bib20
  article-title: Association between habitual dietary flavonoid and lignan intake and colorectal cancer in a Spanish case-control study (the Bellvitge Colorectal Cancer Study)
  publication-title: Cancer Causes Control
– volume: 11
  start-page: 1
  year: 2019
  end-page: 18
  ident: bib23
  article-title: The flavonoid metabolite 2,4,6-trihydroxybenzoic acid is a CDK inhibitor and an anti-proliferative agent: a potential role in cancer prevention
  publication-title: Cancers (Basel).
– year: 2021
  ident: bib24
  article-title: Antiproliferative effect of colonic fermented phenolic compounds from Jaboticaba (Myrciaria trunciflora) fruit peel in a 3d cell model of colorectal cancer
  publication-title: Molecules
– volume: 27
  start-page: 1023
  year: 2009
  end-page: 1037
  ident: bib2
  article-title: Cell adhesion molecules: role and clinical significance in cancer
  publication-title: Cancer Invest
– volume: 18
  start-page: 516
  year: 2006
  end-page: 523
  ident: bib28
  article-title: Integrin-regulated FAK-Src signaling in normal and cancer cells
  publication-title: Curr. Opin. Cell Biol.
– volume: 42
  start-page: 101
  year: 2020
  end-page: 108
  ident: bib13
  article-title: Anti-proliferative effects of a blueberry extract on a panel of tumor cell lines of different origin
  publication-title: Exp. Oncol.
– volume: 105
  start-page: E1489
  year: 2020
  end-page: E1503
  ident: bib32
  article-title: Paraneoplastic β cell dedifferentiation in nondiabetic patients with pancreatic cancer
  publication-title: J. Clin. Endocrinol. Metab.
– volume: 21
  start-page: 1
  year: 2020
  end-page: 24
  ident: bib1
  article-title: Knockdown of α2,3-sialyltransferases impairs pancreatic cancer cell migration, invasion and e-selectin-dependent adhesion
  publication-title: Int. J. Mol. Sci.
– volume: 36
  start-page: 811
  year: 2004
  end-page: 822
  ident: bib30
  article-title: Antioxidant activity and inhibition of matrix metalloproteinases by metabolites of maritime pine bark extract (Pycnogenol
  publication-title: Free Radic. Biol. Med.
– volume: 53
  start-page: 432
  year: 2014
  end-page: 439
  ident: bib22
  article-title: The anthocyanin metabolites gallic acid, 3-O-methylgallic acid, and 2,4,6-trihydroxybenzaldehyde decrease human colon cancer cell viability by regulating pro-oncogenic signals
  publication-title: Mol. Carcinog.
– volume: 53
  start-page: 1
  year: 2005
  end-page: 10
  ident: bib6
  article-title: Fruit and vegetables consumption and gastric cancer: a systematic review and meta-analysis of cohort studies
  publication-title: Nutr. Cancer
– volume: 56
  start-page: 203
  year: 2017
  end-page: 214
  ident: bib14
  article-title: Inhibition of pancreatic cancer cell migration by plasma anthocyanins isolated from healthy volunteers receiving an anthocyanin-rich berry juice
  publication-title: Eur. J. Nutr.
– year: 2001
  ident: bib8
  article-title: Phenolic compounds in berries of black, red, green, and white currants (Ribes sp.)
  publication-title: Antioxid. Redox Signal
– volume: 27
  start-page: 5337
  year: 2017
  end-page: 5343
  ident: bib18
  article-title: Delphinidin inhibits BDNF-induced migration and invasion in SKOV3 ovarian cancer cells
  publication-title: Bioorg. Med. Chem. Lett.
– volume: 9
  start-page: 1
  year: 2019
  end-page: 11
  ident: bib19
  article-title: Dietary delphinidin inhibits human colorectal cancer metastasis associating with upregulation of miR-204-3p and suppression of the integrin/FAK axis
  publication-title: Sci. Rep.
– volume: 13
  start-page: 4007
  year: 2016
  end-page: 4013
  ident: bib27
  article-title: Anthocyanins inhibit trastuzumab-resistant breast cancer in vitro and in vivo
  publication-title: Mol. Med. Rep.
– volume: 744
  start-page: 117
  year: 2012
  end-page: 124
  ident: bib25
  article-title: Analysis of in vitro chemoprevention of genotoxic damage by phytochemicals, as single agents or as combinations
  publication-title: Mutat. Res. - Genet. Toxicol. Environ. Mutagen.
– volume: 65
  start-page: 1582
  year: 2017
  ident: 10.1016/j.biopha.2022.114076_bib21
  article-title: Flavonoid metabolites in human urine during blueberry anthocyanin intake
  publication-title: J. Agric. Food Chem.
  doi: 10.1021/acs.jafc.6b05455
– start-page: 3
  year: 2001
  ident: 10.1016/j.biopha.2022.114076_bib8
  article-title: Phenolic compounds in berries of black, red, green, and white currants (Ribes sp.)
  publication-title: Antioxid. Redox Signal
– volume: 35
  start-page: 64
  year: 2019
  ident: 10.1016/j.biopha.2022.114076_bib29
  article-title: Tinagl1 Suppresses Triple-Negative Breast Cancer Progression and Metastasis by Simultaneously Inhibiting Integrin/FAK and EGFR Signaling
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2018.11.016
– volume: 14
  start-page: 2093
  year: 2005
  ident: 10.1016/j.biopha.2022.114076_bib5
  article-title: Vegetable and fruit intake and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area
  publication-title: Cancer Epidemiol. Biomark. Prev.
  doi: 10.1158/1055-9965.EPI-05-0226
– volume: 42
  start-page: 101
  year: 2020
  ident: 10.1016/j.biopha.2022.114076_bib13
  article-title: Anti-proliferative effects of a blueberry extract on a panel of tumor cell lines of different origin
  publication-title: Exp. Oncol.
  doi: 10.32471/exp-oncology.2312-8852.vol-42-no-2.14766
– volume: 105
  start-page: E1489
  year: 2020
  ident: 10.1016/j.biopha.2022.114076_bib32
  article-title: Paraneoplastic β cell dedifferentiation in nondiabetic patients with pancreatic cancer
  publication-title: J. Clin. Endocrinol. Metab.
  doi: 10.1210/clinem/dgz224
– volume: 18
  start-page: 516
  year: 2006
  ident: 10.1016/j.biopha.2022.114076_bib28
  article-title: Integrin-regulated FAK-Src signaling in normal and cancer cells
  publication-title: Curr. Opin. Cell Biol.
  doi: 10.1016/j.ceb.2006.08.011
– volume: 2101043
  start-page: 1
  year: 2022
  ident: 10.1016/j.biopha.2022.114076_bib12
  article-title: A Screening of Native (Poly)phenols and Gut-Related Metabolites on 3D HCT116 Spheroids Reveals Gut Health Benefits of a Flavan-3-ol Metabolite
  publication-title: Mol. Nutr. Food Res.
– volume: 36
  start-page: 811
  year: 2004
  ident: 10.1016/j.biopha.2022.114076_bib30
  article-title: Antioxidant activity and inhibition of matrix metalloproteinases by metabolites of maritime pine bark extract (Pycnogenol
  publication-title: Free Radic. Biol. Med.
  doi: 10.1016/j.freeradbiomed.2003.12.017
– volume: 20
  start-page: 5570
  year: 2021
  ident: 10.1016/j.biopha.2022.114076_bib11
  article-title: Acylated anthocyanins: a review on their bioavailability and effects on postprandial carbohydrate metabolism and inflammation
  publication-title: Compr. Rev. Food Sci. Food Saf.
  doi: 10.1111/1541-4337.12836
– volume: 44
  start-page: 152
  year: 2013
  ident: 10.1016/j.biopha.2022.114076_bib7
  article-title: Nutrients from fruit and vegetable consumption reduce the risk of pancreatic cancer
  publication-title: J. Gastrointest. Cancer
  doi: 10.1007/s12029-012-9441-y
– volume: 9
  start-page: 1
  year: 2019
  ident: 10.1016/j.biopha.2022.114076_bib19
  article-title: Dietary delphinidin inhibits human colorectal cancer metastasis associating with upregulation of miR-204-3p and suppression of the integrin/FAK axis
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-019-55505-z
– volume: 11
  start-page: 1
  year: 2019
  ident: 10.1016/j.biopha.2022.114076_bib23
  article-title: The flavonoid metabolite 2,4,6-trihydroxybenzoic acid is a CDK inhibitor and an anti-proliferative agent: a potential role in cancer prevention
  publication-title: Cancers (Basel).
  doi: 10.3390/cancers11030427
– volume: 21
  start-page: 1
  year: 2020
  ident: 10.1016/j.biopha.2022.114076_bib1
  article-title: Knockdown of α2,3-sialyltransferases impairs pancreatic cancer cell migration, invasion and e-selectin-dependent adhesion
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms21176239
– volume: 359
  year: 2021
  ident: 10.1016/j.biopha.2022.114076_bib9
  article-title: Aronia berry polyphenols have matrix-dependent effects on the gut microbiota
  publication-title: Food Chem.
  doi: 10.1016/j.foodchem.2021.129831
– volume: 167
  start-page: 2257
  year: 2012
  ident: 10.1016/j.biopha.2022.114076_bib17
  article-title: Detection and clinical significance of cd44v6 and integrin-β1 in pancreatic cancer patients using a triplex real-time RT-PCR assay
  publication-title: Appl. Biochem. Biotechnol.
  doi: 10.1007/s12010-012-9752-2
– volume: 27
  start-page: 5337
  year: 2017
  ident: 10.1016/j.biopha.2022.114076_bib18
  article-title: Delphinidin inhibits BDNF-induced migration and invasion in SKOV3 ovarian cancer cells
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/j.bmcl.2017.09.024
– volume: 27
  start-page: 1023
  year: 2009
  ident: 10.1016/j.biopha.2022.114076_bib2
  article-title: Cell adhesion molecules: role and clinical significance in cancer
  publication-title: Cancer Invest
  doi: 10.3109/07357900902769749
– volume: 29
  start-page: 227
  year: 2014
  ident: 10.1016/j.biopha.2022.114076_bib26
  article-title: Anthocyans as tertiary chemopreventive agents in bladder cancer: anti-oxidant mechanisms and interaction with mitomycin C
  publication-title: Mutagenesis
  doi: 10.1093/mutage/geu009
– volume: 65
  start-page: 6477
  year: 2017
  ident: 10.1016/j.biopha.2022.114076_bib10
  article-title: Exploring the colonic metabolism of grape and strawberry anthocyanins and their in vitro apoptotic effects in HT-29 colon cancer cells
  publication-title: Antioxid. Redox Signal.
– volume: 92
  start-page: 13767
  year: 2020
  ident: 10.1016/j.biopha.2022.114076_bib16
  article-title: Characterization of the Human Exposome by a Comprehensive and Quantitative Large-Scale Multianalyte Metabolomics Platform
  publication-title: Anal. Chem.
  doi: 10.1021/acs.analchem.0c02008
– volume: 13
  start-page: 4007
  year: 2016
  ident: 10.1016/j.biopha.2022.114076_bib27
  article-title: Anthocyanins inhibit trastuzumab-resistant breast cancer in vitro and in vivo
  publication-title: Mol. Med. Rep.
  doi: 10.3892/mmr.2016.4990
– volume: 53
  start-page: 1
  year: 2005
  ident: 10.1016/j.biopha.2022.114076_bib6
  article-title: Fruit and vegetables consumption and gastric cancer: a systematic review and meta-analysis of cohort studies
  publication-title: Nutr. Cancer
  doi: 10.1207/s15327914nc5301_1
– volume: 744
  start-page: 117
  year: 2012
  ident: 10.1016/j.biopha.2022.114076_bib25
  article-title: Analysis of in vitro chemoprevention of genotoxic damage by phytochemicals, as single agents or as combinations
  publication-title: Mutat. Res. - Genet. Toxicol. Environ. Mutagen.
  doi: 10.1016/j.mrgentox.2012.01.011
– volume: 17
  start-page: 172
  year: 2017
  ident: 10.1016/j.biopha.2022.114076_bib3
  article-title: Cancer metastasis - Tricks of the trade
  publication-title: Bosn. J. Basic Med. Sci.
– volume: 53
  start-page: 432
  year: 2014
  ident: 10.1016/j.biopha.2022.114076_bib22
  article-title: The anthocyanin metabolites gallic acid, 3-O-methylgallic acid, and 2,4,6-trihydroxybenzaldehyde decrease human colon cancer cell viability by regulating pro-oncogenic signals
  publication-title: Mol. Carcinog.
  doi: 10.1002/mc.21974
– volume: 56
  start-page: 203
  year: 2017
  ident: 10.1016/j.biopha.2022.114076_bib14
  article-title: Inhibition of pancreatic cancer cell migration by plasma anthocyanins isolated from healthy volunteers receiving an anthocyanin-rich berry juice
  publication-title: Eur. J. Nutr.
  doi: 10.1007/s00394-015-1070-3
– volume: 35
  start-page: 347
  year: 2019
  ident: 10.1016/j.biopha.2022.114076_bib4
  article-title: Integrin signaling in cancer: mechanotransduction, stemness, epithelial plasticity, and therapeutic resistance
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2019.01.007
– volume: 24
  start-page: 549
  year: 2013
  ident: 10.1016/j.biopha.2022.114076_bib20
  article-title: Association between habitual dietary flavonoid and lignan intake and colorectal cancer in a Spanish case-control study (the Bellvitge Colorectal Cancer Study)
  publication-title: Cancer Causes Control
  doi: 10.1007/s10552-012-9992-z
– volume: 67
  start-page: 1771
  year: 2019
  ident: 10.1016/j.biopha.2022.114076_bib31
  article-title: Anthocyanins: from sources and bioavailability to cardiovascular- health benefits and molecular mechanisms of action
  publication-title: J. Agric. Food Chem.
  doi: 10.1021/acs.jafc.8b06737
– volume: Vol. 11
  start-page: 1341
  year: 2022
  ident: 10.1016/j.biopha.2022.114076_bib15
  article-title: Influence of Plasma-Isolated Anthocyanins and Their Metabolites on Cancer Cell Migration (HT-29 and Caco-2) In Vitro: Results of the ATTACH Study
  publication-title: Antioxidants 2022
– start-page: 26
  year: 2021
  ident: 10.1016/j.biopha.2022.114076_bib24
  article-title: Antiproliferative effect of colonic fermented phenolic compounds from Jaboticaba (Myrciaria trunciflora) fruit peel in a 3d cell model of colorectal cancer
  publication-title: Molecules
SSID ssj0005638
Score 2.4165728
Snippet Pancreatic cancer is primarily considered to be a metastatic disease with a low 5-year survival rate. We aimed to detect if plasma-isolated anthocyanins and...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 114076
SubjectTerms Adhesion molecules
Anthocyanins
Anthocyanins - pharmacology
Cell Line, Tumor
Cross-Over Studies
Endothelial Cells - metabolism
Healthy Volunteers
Humans
Metabolomics
Migration
NF-kappa B - metabolism
Pancreatic cancer cells
Pancreatic Neoplasms
Pancreatic Neoplasms - pathology
Tandem Mass Spectrometry
Title Plasma anthocyanins and their metabolites reduce in vitro migration of pancreatic cancer cells, PANC-1, in a FAK- and NF-kB dependent manner: Results from the ATTACH-study a randomized, controlled, crossover trial in healthy subjects
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0753332222014652
https://dx.doi.org/10.1016/j.biopha.2022.114076
https://www.ncbi.nlm.nih.gov/pubmed/36516693
https://www.proquest.com/docview/2754860853
Volume 158
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELZWi4S4IFhe5bEaJLSnmqaJHw23UFEVVltV0JX2FtmOuwq0yapJkcqB_8u_wBMnXZBAi7glkcdO7C8zk3jmG0JeDblaYkljygWTlMWBpnqkAhrzZWY1ywKfIXc2E9Nz9uGCXxyQcZcLg2GVre73Or3R1u2VQTubg6s8H3xyxi6KcKMgRAIUjnqYMYkof_39lzAP0VSzxsYUW3fpc02Ml85LJGUKnSFD0twAmUf-bJ7-5n42Zmhyj9xt_UdI_C3eJwe2OCK3z9od8iNyMvdc1Ls-LK5Tq6o-nMD8mqV694D8mDu_ea1AIXuA2akiLyp3kkGzdQBrWzt4YIJyBRukd7WQF_A1rzclrPNLjxsol-C0iXc8DRhE0AZwL8ANOE9mYzrso5iCSXJKm95nE_rlLXSld2tYK6z99QY-2mq7qivAdBe8BUgWi2Q8pQ39revAmdSsXOffbNaHNrx-1RzjNGIYKjT1R3A0n9q5g2qr8SdT9ZCcT94tXF9t3QdqmBjWNAuZlDLWgQmt0SNjg9DqWMeRtszYkVLuG1IvreGKBYY5PIVKCIm-jBVhLG30iBwWZWGfEHBQjIVmikmNvms24kh7arTMrMMO5z0SdcudmpYUHWtzrNIu-u1z6kGSIkhSD5IeoXupK08KckN73iEp7RJenYpOndW6QU7u5X57Kf5B8mUH2NTpC1x4VdhyW6Wh5Fh3zHlpPfLYI3n_DJHgQyHi6Ol_j_uM3HFnkQ9rf04O683WvnBeW62Pm9fymNxK3p9OZz8B9AZCwA
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELZWuxJwQbC8ynOQ0J5qNU1sp-EWKqou3VYVdKW9RbbjrgJtsmpSpPKP-Rd44qQVEmgRt7zGTuwvM5N45htC3vW5XGJJY8oFCymLPEXVQHo04svUKJZ6LkNuOhPjS_bpil8dkWGbC4NhlY3udzq91tbNkV4zmr2bLOt9scYuCHChwEcCFG718AmyU_FjchKfT8azQ6SHqAta4_UUBdoMujrMS2UF8jL51pYhb66H5CN_tlB_80BrSzR6QO43LiTE7i4fkiOTn5I702aR_JSczR0d9a4Li0N2VdmFM5gfiKp3j8jPuXWd1xIkEgjoncyzvLQ7KdSrB7A2lUUI5iiXsEGGVwNZDt-zalPAOrt20IFiCVahON9Tg0YQbQCXA2yH83g2pP0uikkYxRNatz4b0W8foK2-W8FaYvmv9_DZlNtVVQJmvOAtQLxYxMMxrRlwbQPWqqbFOvth0i40EfarehuHESNRoS5Bgr257M4dlFuF_5nKx-Ry9HFh22pKP1DNRL-iqc_CMIyUp32j1UAbzzcqUlGgDNNmIKX9jFRLo7lknmYWUr4UIkR3xgg_Ck3whBznRW6eEbBojIRikoUK3dd0wJH5VKswNRY-nHdI0E53ohtedCzPsUraALiviQNJgiBJHEg6hO6lbhwvyC3X8xZJSZvzarV0Yg3XLXLhXu639-IfJN-2gE2sysCJl7kptmXihxxLj1lHrUOeOiTvnyEQvC9EFDz_737fkLvjxfQiuTifTV6Qe_ZM4KLcX5LjarM1r6wTV6nXzUv6C9stRXE
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Plasma+anthocyanins+and+their+metabolites+reduce+in+vitro+migration+of+pancreatic+cancer+cells%2C+PANC-1%2C+in+a+FAK-+and+NF-kB+dependent+manner%3A+Results+from+the+ATTACH-study+a+randomized%2C+controlled%2C+crossover+trial+in+healthy+subjects&rft.jtitle=Biomedicine+%26+pharmacotherapy&rft.au=Mostafa%2C+Hamza&rft.au=Behrendt%2C+Inken&rft.au=Mero%C3%B1o%2C+Tom%C3%A1s&rft.au=Gonz%C3%A1lez-Dom%C3%ADnguez%2C+Ra%C3%BAl&rft.date=2023-02-01&rft.eissn=1950-6007&rft.volume=158&rft.spage=114076&rft_id=info:doi/10.1016%2Fj.biopha.2022.114076&rft_id=info%3Apmid%2F36516693&rft.externalDocID=36516693
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0753-3322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0753-3322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0753-3322&client=summon